NCT01078935 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Status UNKNOWN Phase PHASE4
NCT01065571 Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity Status COMPLETED Phase NA
NCT01059344 Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT01020708 Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT01011322 A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis Status UNKNOWN Phase PHASE2
NCT01010815 Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis Status UNKNOWN Phase N/A
NCT01004185 Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis Status TERMINATED Phase PHASE3
NCT01002287 An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery Status TERMINATED Phase NA
NCT00968721 Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use Status TERMINATED Phase N/A
NCT00961948 Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis Status COMPLETED Phase N/A
NCT00951548 Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis Status COMPLETED Phase NA